Lesions which cause defective apoptosis, such as del17p-, resulting in the deletion of the TP53 locus or inactivating TP53 gene mutations, are detected in a relative minority of CLL cases, frequently at advanced stages and again in only a proportion of the cells of a clone [20,21]. The gene discussed is TP53; the disease is B-cell chronic lymphocytic leukemia.